[Differential features of SSRIs].
The goal of this study is to review the pharmacologic profiles of the selective serotonin reuptake inhibitors (SSRIs) presently available, with particular emphasis placed on therapeutically relevant distinctions.
Cervera
S
S
Departamento de Psiquiatría y Psicología Médica, Facultad de Medicina, Universidad de Navarra.
D000818:Animals; D015283:Citalopram / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D003863:Depression / Q000503:physiopathology; D004347:Drug Interactions; D062787:Drug Overdose; D005473:Fluoxetine / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D016666:Fluvoxamine / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D006207:Half-Life; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy; D009325:Nausea / Q000139:chemically induced; D017374:Paroxetine / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D011985:Receptors, Serotonin / Q000187:drug effects / Q000502:physiology; D012701:Serotonin / Q000502:physiology; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D020280:Sertraline / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology; D007319:Sleep Initiation and Maintenance Disorders / Q000139:chemically induced; D012894:Sleep Stages / Q000187:drug effects
D015283:Citalopram; D005473:Fluoxetine; D016666:Fluvoxamine; D017374:Paroxetine; D011985:Receptors, Serotonin; D012701:Serotonin; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline
Aspectos diferenciales de los ISRS.